Sponsor:
Mayo Clinic
Code:
NCT06053333
Conditions
Malignant Hepatobiliary Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Non-Interventional Study
Brief summary:
Conditions
Malignant Hepatobiliary Neoplasm
Study ID
NCT06053333
Start date
Jul 17, 2023
Status verified date
Feb, 2026
Completion date
Jul 17, 2028
Anticipated
Primary completion date
Jul 17, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
400 participants
Anticipated
Arms
Observational
Interventions
Non-Interventional Study
Primary outcome measure
Central contacts
Locations
Mayo Clinic in Rochester
Recruiting
Rochester, Minnesota, United States, 55905
Contacts
Principal Investigator:
Nguyen H. Tran, M.D.
Sponsor
Mayo Clinic
Last update posted
Feb 4, 2026
Last verified
Feb, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-02-04.